3/30
02:02 am
fgen
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/28
07:00 am
fgen
FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology
High
Report
FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology
3/22
02:04 am
fgen
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/18
12:11 pm
fgen
FibroGen, Inc. (NASDAQ: FGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
FibroGen, Inc. (NASDAQ: FGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
3/17
08:20 pm
fgen
FibroGen, Inc. (FGEN) Q4 2024 Earnings Call Transcript [Seeking Alpha]
High
Report
FibroGen, Inc. (FGEN) Q4 2024 Earnings Call Transcript [Seeking Alpha]
3/17
04:16 pm
fgen
FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
High
Report
FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
3/17
04:05 pm
fgen
FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results
High
Report
FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results
3/14
02:00 am
fgen
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/6
02:09 am
fgen
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/3
04:45 pm
fgen
FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results
Medium
Report
FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results
2/21
02:06 am
fgen
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
2/20
04:54 pm
fgen
This Small Cap Soared Following Subsidiary Sale Announcement Worth $160M [Globe and Mail, The (Toronto, Canada)]
Low
Report
This Small Cap Soared Following Subsidiary Sale Announcement Worth $160M [Globe and Mail, The (Toronto, Canada)]
2/20
12:19 pm
fgen
FibroGen, Inc. (NASDAQ: FGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
FibroGen, Inc. (NASDAQ: FGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
2/20
06:30 am
fgen
FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million
High
Report
FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million
2/13
01:58 am
fgen
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
2/5
02:34 am
fgen
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
1/1
02:30 am
fgen
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
FibroGen, Inc. (NASDAQ: FGEN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.